Regulatory Filings; Regulatory Approvals. (a) Novo Nordisk shall, at its own cost and discretion, develop and obtain Regulatory Approval for the Licensed Product. Except as otherwise set forth below, Novo Nordisk shall be solely responsible for all regulatory and filing activities, and shall solely own all regulatory documents and registrations, related to Licensed Product, including all clinical trial applications and marketing applications filed with any Regulatory Authority in any jurisdiction.
Appears in 4 contracts
Samples: Development and License Agreement, Development and License Agreement, Collaboration, Development and License Agreement (Zosano Pharma Corp)
